ES2003518A6 - Un metodo de produccion del polipeptido de superoxido dismutasa de manganeso humana o un analogo o un mutante de este - Google Patents

Un metodo de produccion del polipeptido de superoxido dismutasa de manganeso humana o un analogo o un mutante de este

Info

Publication number
ES2003518A6
ES2003518A6 ES8603083A ES8603083A ES2003518A6 ES 2003518 A6 ES2003518 A6 ES 2003518A6 ES 8603083 A ES8603083 A ES 8603083A ES 8603083 A ES8603083 A ES 8603083A ES 2003518 A6 ES2003518 A6 ES 2003518A6
Authority
ES
Spain
Prior art keywords
polypeptide
mutant
analog
superoxide dismutase
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8603083A
Other languages
English (en)
Spanish (es)
Inventor
Jacob R Hartman
Yaffa Beck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Savient Pharmaceuticals Inc
Original Assignee
Savient Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Savient Pharmaceuticals Inc filed Critical Savient Pharmaceuticals Inc
Publication of ES2003518A6 publication Critical patent/ES2003518A6/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0089Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44Oxidoreductases (1)
    • A61K38/446Superoxide dismutase (1.15)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES8603083A 1985-11-22 1986-11-18 Un metodo de produccion del polipeptido de superoxido dismutasa de manganeso humana o un analogo o un mutante de este Expired ES2003518A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80109085A 1985-11-22 1985-11-22
US90705186A 1986-09-12 1986-09-12

Publications (1)

Publication Number Publication Date
ES2003518A6 true ES2003518A6 (es) 1988-11-01

Family

ID=27122291

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8603083A Expired ES2003518A6 (es) 1985-11-22 1986-11-18 Un metodo de produccion del polipeptido de superoxido dismutasa de manganeso humana o un analogo o un mutante de este

Country Status (21)

Country Link
JP (2) JP2609449B2 (enExample)
AT (1) AT400443B (enExample)
AU (1) AU607897B2 (enExample)
BE (1) BE905796A (enExample)
CA (1) CA1341362C (enExample)
CH (1) CH676990A5 (enExample)
DE (1) DE3639725C2 (enExample)
DK (1) DK534686A (enExample)
ES (1) ES2003518A6 (enExample)
FI (1) FI90353C (enExample)
FR (1) FR2590591B1 (enExample)
GB (1) GB2183658B (enExample)
GR (1) GR862713B (enExample)
HK (1) HK75195A (enExample)
IE (1) IE59498B1 (enExample)
IL (2) IL106449A (enExample)
IT (1) IT1205418B (enExample)
LU (1) LU86676A1 (enExample)
NL (1) NL8602960A (enExample)
PT (1) PT83792B (enExample)
SE (1) SE8604884L (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610520B1 (en) 1985-11-22 2003-08-26 Bio-Technology General Corp. Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby
JPS62215532A (ja) * 1986-03-18 1987-09-22 Ube Ind Ltd 抗炎症剤
JPH0643341B2 (ja) * 1986-03-27 1994-06-08 宇部興産株式会社 臓器機能改善剤
JPH0643340B2 (ja) * 1986-09-03 1994-06-08 宇部興産株式会社 虚血性心疾患治療薬
JPS6377822A (ja) * 1986-09-18 1988-04-08 Ube Ind Ltd 臓器機能改善剤
US6326003B1 (en) 1986-10-14 2001-12-04 Chiron Corporation Manganese superoxide dismutase cloning and expression in microorganisms
US5260204A (en) * 1987-03-14 1993-11-09 Boehringer Ingelheim International Gmbh Human manganese superoxide dismutase (hMn-SOD)
DE3854872D1 (de) * 1987-03-14 1996-02-22 Boehringer Ingelheim Int Humane Mangan-Superoxiddismutase (hMn-SOD)
IL85876A (en) * 1987-03-27 2001-11-25 Bio Technology General Corp Human manganese superoxide dismutase or analogs or mutants and uses thereof
JPH01233228A (ja) * 1988-03-11 1989-09-19 Toyo Jozo Co Ltd 悪性腫瘍細胞転移防止剤
US5772996A (en) * 1990-08-03 1998-06-30 Public Health Laboratory Service Board Pharmaceutical compositions containing superoxide dismutase from Bacillus Stearothermophilus and Bacillus Caldotenax
DE4038563A1 (de) * 1990-12-04 1992-06-11 Gruenenthal Gmbh Verwendung von superoxiddismutasen zur prophylaxe und/oder behandlung von organversagen bei risikopatienten mit polytrauma
EP0587055B1 (de) * 1992-09-09 2001-12-05 Bio-Technology General Corporation Verwendung von Mangan-Superoxiddismutase (Mn-SOD) zur Herstellung von Arzneimitteln zur Behandlung von Erkrankungen in niedriger Dosierung
DE4239877C1 (de) * 1992-11-27 1994-03-17 Boehringer Ingelheim Int Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung
WO2025178510A1 (ru) * 2024-02-21 2025-08-28 Евгений Владимирович ГРИГОРЬЕВ Способ применения супероксиддисмутазы 2 в качестве антиоксиданта в сверхмалых дозировках

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56102787A (en) * 1980-01-18 1981-08-17 Mamoru Sugiura Preparation of human placenta superoxide dismutase
BG49718A3 (bg) * 1983-07-15 1992-01-15 Bio- Technology General Corp Метод за получаване на полипептид със супероксиддисмутазна активност
DE3486493T2 (de) * 1983-10-03 2003-05-22 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Klonieren von Superoxiddismutase und Expression in Mikroorganismen

Also Published As

Publication number Publication date
BE905796A (fr) 1987-03-16
IT8667865A0 (it) 1986-11-21
IL106449A0 (en) 1993-11-15
DE3639725A1 (de) 1987-07-23
HK75195A (en) 1995-05-26
LU86676A1 (fr) 1987-05-04
IT1205418B (it) 1989-03-15
DK534686D0 (da) 1986-11-07
IL80702A0 (en) 1987-02-27
JPS62289187A (ja) 1987-12-16
PT83792B (pt) 1989-01-17
GB8627294D0 (en) 1986-12-17
GB2183658A (en) 1987-06-10
AT400443B (de) 1995-12-27
SE8604884D0 (sv) 1986-11-14
CH676990A5 (enExample) 1991-03-28
NL8602960A (nl) 1987-06-16
FI864756A0 (fi) 1986-11-21
IL106449A (en) 1997-02-18
IE862851L (en) 1987-05-22
FR2590591B1 (fr) 1989-12-01
FI90353B (fi) 1993-10-15
IE59498B1 (en) 1994-03-09
JP2967557B2 (ja) 1999-10-25
JP2609449B2 (ja) 1997-05-14
AU607897B2 (en) 1991-03-21
AU6497586A (en) 1987-05-28
PT83792A (en) 1986-12-01
FR2590591A1 (fr) 1987-05-29
JPH08289792A (ja) 1996-11-05
DE3639725C2 (de) 1998-02-19
GR862713B (en) 1987-03-24
CA1341362C (en) 2002-05-28
DK534686A (da) 1987-05-23
SE8604884L (sv) 1987-05-23
FI90353C (fi) 1994-01-25
FI864756A7 (fi) 1987-05-23
GB2183658B (en) 1990-04-25
ATA308986A (de) 1995-05-15

Similar Documents

Publication Publication Date Title
ES2003518A6 (es) Un metodo de produccion del polipeptido de superoxido dismutasa de manganeso humana o un analogo o un mutante de este
NO173741C (no) DNA-sekvens for modifisert protein C, vektor inneholdende denne, patte-dyrceller transfektert med vektorer, og fremgangsmaate for fremstilling av nevnte protein
IL86480A (en) Recombinant dna coding for human proapolipoprotein a-1,expression vectors containing it and cells transformed by said expression vector
CA2400295A1 (en) Modified factor viii
Hachimori et al. Phospholipase A2 of Crotalus atrox. Molecular weight and other properties
HUT46739A (en) Human manganese-superoxid-dismutale and process for its production
AU7659298A (en) Recombinant lactoferrin, methods of production from plants and uses
AU3307797A (en) A method for increasing hemoprotein production in filamentous fungi
CA2102702A1 (en) Vitamin K-Dependent Carboxylase
BR9811096A (pt) Sequências, moléculas, vetores e vacinas de dna recombinante para doença do calcivìrus felino e processo para a produção e o uso dos mesmos
NO970312L (no) Karbonmonoksidavhengige guanylylcyklase modifiseringsmidler
NZ334568A (en) Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof
WO2004057003A3 (de) Verfahren zur herstellung von aminosäuren mittels transgener organismen
HUT52551A (en) Process for production of neutrophil-activizating factor
Bolgiano et al. Kinetics of the interaction of the cytochrome c oxidase of Paracoccus denitrificans with its own and bovine cytochrome c
MY130321A (en) Expression vector containing pl promoter and engineered restriction site for convenient replacement of ribosomal binding site, plasmid containing the vectors, hosts containing the plasmids and relatedmethods
EP0387355A4 (en) Luciferase, luciferase-coding gene, and process for preparing luciferase
Saeki et al. Two distinct ferredoxins from Rhodobacter capsulatus: complete amino acid sequences and molecular evolution
EP0422217A4 (en) Human recombinant placental ribonuclease inhibitor and method of production
JPH114690A (ja) アルキルハイドロパーオキシドレダクターゼ遺伝子
HUP9901817A2 (hu) Kukoricából származó elágazásbontó enzimet kódoló nukleinsavmolekulák
Osatomi et al. Purification and sequence of manganese superoxide dismutase from Japanese flounder (Paralichthys olivaceus) hepato-pancreas
Abrams THE PURIFICATION AND CHARACTERIZATION OF HYDROPEROXIDASE FROM VITREOSCILLA.
MX9605473A (es) Polipeptido hk2 recombinante.
KR870005096A (ko) 인체의 망간 수퍼옥사이드 디스무타아제 cDNA, 박테리아에서의 이의 표현 및 효소력이 있는 인체망간 수퍼옥사이드 디스무타아제의 회수방법

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2006-11-18